FDA Awards Genetesis Breakthrough Device Designation for CardioFlux® Imaging Technology

Dec 15, 2020

Home News Home Media Coverage FDA Awards Genetesis Breakthrough Device Designation for CardioFlux® Imaging Technology

Related News & Articles

Apr 21, 2025
Announcements

TDK Ventures announces launch of $150 Million Fund 3 to catalyze iconic companies

Mar 06, 2025
Announcements

TDK Ventures Invests in Spiritus to Transform Carbon Dioxide Removal

More News

Back to Insights

Back to Announcements

Submit Your Project (Entrepreneurs Only)